Ulcerative Colitis study: Virtual chromoendoscopy vs Chromoendoscopy
Official title Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis
ClinicalTrials.gov ID: NCT01882205
What this study is testing
- What it's testing
- The study aims to see if newer, faster camera tools are as good as the standard dye method for spotting abnormal tissue in the colon.
- Who it's for
- The study is looking for adults who have had ulcerative colitis affecting more than just the rectum for a long time.
- What's involved
- Participants will have a colonoscopy where doctors use different camera settings to look for abnormal spots and take small tissue samples.
- Time commitment
- The study involves a single colonoscopy procedure to compare the imaging methods.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with longstanding ulcerative colitis ( 8 years after diagnosis or pancolitis and 10 years after diagnosis of left-sided colitis)
- Signed informed consent form
- Previous surveillance endoscopy \> 1 year
You likely can't join if
- Active ulcerative colitis, \> 20 cm from the margo ani
- Personal history of colorectal cancer
- Allergy or intolerance to methylene blue
- Refusing or incapable to agree with informed consent
- Age younger than 18 years
- Pregnant women
The study team makes the final eligibility decision.
Where it is enrolling
- Leuven, Belgium
- Roeselaere, Belgium
- Montreal, Canada
- Copenhagen, Denmark
- Maastricht, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Leuven, Belgium; Roeselaere, Belgium; Montreal, Canada; Copenhagen, Denmark; Maastricht, Netherlands. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.